Cargando…
Differentiation and Regulation of T(H) Cells: A Balancing Act for Cancer Immunotherapy
Current success of immunotherapy in cancer has drawn attention to the subsets of T(H) cells in the tumor which are critical for activation of anti-tumor response either directly by themselves or by stimulating cytotoxic T cell activity. However, presence of immunosuppressive pro-tumorigenic T(H) sub...
Autores principales: | Basu, Amrita, Ramamoorthi, Ganesan, Albert, Gabriella, Gallen, Corey, Beyer, Amber, Snyder, Colin, Koski, Gary, Disis, Mary L., Czerniecki, Brian J., Kodumudi, Krithika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126720/ https://www.ncbi.nlm.nih.gov/pubmed/34012451 http://dx.doi.org/10.3389/fimmu.2021.669474 |
Ejemplares similares
-
Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinoma
por: Ramamoorthi, Ganesan, et al.
Publicado: (2022) -
Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response
por: Kodumudi, Krithika N., et al.
Publicado: (2019) -
Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination
por: Zachariah, Nadia Nocera, et al.
Publicado: (2021) -
Murine Dendritic Cells Grown in Serum-Free Culture Show Potent Therapeutic Activity when Loaded with Novel Th Epitopes in an Orthotopic Model of HER2(pos) Breast Cancer
por: Showalter, Loral E., et al.
Publicado: (2021) -
Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4(+) Th1 Responses and Potential Use as a Cancer Vaccine
por: Basu, Amrita, et al.
Publicado: (2022)